J&J says vaccine offers 100% protection against coronavirus deaths

Johnson & Johnson’s one-shot vaccine generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunisation campaign.

In the more than 44,000-person study, the vaccine prevented 66 per cent of moderate to severe cases of Covid-19, according to a company statement on Friday. And it was particularly effective at stopping severe disease, preventing 85 per cent of severe infections and 100 per cent of hospitalisations and deaths.

Based on the result, J&J plans to file for an emergency-use authorization in the U.S. in early February. The drug giant’s top scientist said